UPDATE: Morgan Stanley Reiterates on Aetna Following Company Investor Day

In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on Aetna AET, but removed the $83.00 price target. In the report, Morgan Stanley noted, “AET remains committed to growing operating earnings in 2014 and beyond. Despite expectations for flat operating EPS of 'at least' $6.25 as a floor for next year, management sounds confident in its ability to grow both operating earnings and operating EPS next year. We are particularly encouraged by AET's outlook for 1) additional growth in 2015, 2) a return to low double-digit EPS growth in 2016, and 3) its long-term goal to double 2013 revenue of $47B to $100B by 2020.” Aetna closed on Thursday at $65.14.